Exact Mass: 370.2468

Exact Mass Matches: 370.2468

Found 64 metabolites which its exact mass value is equals to given mass value 370.2468, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3-Oxo-4,6-choladienoic acid

(4R)-4-[(1S,2R,10S,11S,14R,15R)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-6,8-dien-14-yl]pentanoic acid

C24H34O3 (370.2508)


3-Oxo-4,6-choladienoic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. 3-Oxo-4,6-choladien-24-oic acid is an endogenous metabolite. 3-Oxo-4,6-choladien-24-oic acid exsists in the urine of patients with hepatobiliary disease[1].

   

Antibiotic SB 202742

2-[(8E,11E,14Z)-heptadeca-8,11,14-trien-1-yl]-6-hydroxybenzoic acid

C24H34O3 (370.2508)


Antibiotic SB 202742 is found in fruits. Antibiotic SB 202742 is a constituent of Spondias mombin (yellow mombin). Constituent of Spondias mombin (yellow mombin). Antibiotic SB 202742 is found in fruits.

   

Rimexolone

(2R,13R,14S,15S,17S)-17-hydroxy-2,13,14,15-tetramethyl-14-propanoyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-3,6-dien-5-one

C24H34O3 (370.2508)


Rimexolone is only found in individuals that have used or taken this drug. It is a glucocorticoid steroid used to treat inflammation in the eye. It is marketed as a 1\\% eye drop solution under the trade name VexolRimexolone is a glucocorticoid receptor agonist. The antiinflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition of arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. By binding to the glucocorticoid receptor, this drug ultimately leads to changes in genetic transcription involving the lipocortins and prostaglandins.

   

Adb-chminaca, (+/-)-

N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

C21H30N4O2 (370.2369)


   

Methoxy arachidonyl fluorophosphonate

methyl fluoro(icosa-5,8,11,14-tetraen-1-yl)phosphinate

C21H36FO2P (370.2437)


   

N-[1'-(Aminocarbonyl)-2',2'-dimethylpropyl]-1-(cyclohexylmethyl)-1h-indazole-3-carboxamide

N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

C21H30N4O2 (370.2369)


   

19-Furan-2-yl-nonadeca-5,7-diynoic acid methyl ester

19-Furan-2-yl-nonadeca-5,7-diynoic acid methyl ester

C24H34O3 (370.2508)


   
   

SCHEMBL2477691

SCHEMBL2477691

C24H34O3 (370.2508)


   

6beta-cinnamoyloxy-4beta-hydroxyeudesmane

6beta-cinnamoyloxy-4beta-hydroxyeudesmane

C24H34O3 (370.2508)


   

2-[(6Z,9Z,12Z)-heptadeca-6,9,12-trienyl]-6-hydroxybenzoic acid

2-[(6Z,9Z,12Z)-heptadeca-6,9,12-trienyl]-6-hydroxybenzoic acid

C24H34O3 (370.2508)


   

cananginone A

cananginone A

C24H34O3 (370.2508)


   

Antibiot SB 202742

Antibiot SB 202742

C24H34O3 (370.2508)


   

(4E,8E)-1-(2-hydroxy-4-methoxyphenyl)-5,9,13-trimethyltetradeca-4,8,12-trien-1-one|4-O-methyldshamirone|O(7)-methyl-2-nor-1,2-secoammoresinol

(4E,8E)-1-(2-hydroxy-4-methoxyphenyl)-5,9,13-trimethyltetradeca-4,8,12-trien-1-one|4-O-methyldshamirone|O(7)-methyl-2-nor-1,2-secoammoresinol

C24H34O3 (370.2508)


   

3-oxo-chol-1,4-dien-24-oic acid

3-oxo-chol-1,4-dien-24-oic acid

C24H34O3 (370.2508)


   

MLS002154105-01!Rimexolone49697-38-3

MLS002154105-01!Rimexolone49697-38-3

C24H34O3 (370.2508)


   

(R)-4-((8S,9S,10R,13R,14S,17R)-10,13-dimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((8S,9S,10R,13R,14S,17R)-10,13-dimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H34O3 (370.2508)


   

(20S,22E)-3β-Hydroxychola-5,16,22-trien-24-oic Acid

(20S,22E)-3β-Hydroxychola-5,16,22-trien-24-oic Acid

C24H34O3 (370.2508)


   

3-Oxo-5β-chola-8(14),11-dien-24-oic Acid

3-Oxo-5β-chola-8(14),11-dien-24-oic Acid

C24H34O3 (370.2508)


   

3-Oxo-5β-chola-7,9(11)-dien-24-oic Acid

3-Oxo-5β-chola-7,9(11)-dien-24-oic Acid

C24H34O3 (370.2508)


   

3-Oxo-5β-chola-7,11-dien-24-oic Acid

3-Oxo-5β-chola-7,11-dien-24-oic Acid

C24H34O3 (370.2508)


   

(22E)-3β-Hydroxychola-5,16,22-trien-24-oic Acid

(22E)-3β-Hydroxychola-5,16,22-trien-24-oic Acid

C24H34O3 (370.2508)


   

Rimexolone

Rimexolone

C24H34O3 (370.2508)


H - Systemic hormonal preparations, excl. sex hormones and insulins > H02 - Corticosteroids for systemic use > H02A - Corticosteroids for systemic use, plain > H02AB - Glucocorticoids D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid

   

3-Oxo-4,6-choladienoic acid

3-Oxo-4,6-choladienoic acid

C24H34O3 (370.2508)


   

Methyl Arachidonyl Fluorophosphonate

5Z,8Z,11Z,14Z-eicosatetraenyl-phosphonofluoridic acid, methyl ester

C21H36FO2P (370.2437)


D004791 - Enzyme Inhibitors

   

Antibiotic SB 202742

2-[(8E,11E,14Z)-heptadeca-8,11,14-trien-1-yl]-6-hydroxybenzoic acid

C24H34O3 (370.2508)


   

Mutanamide

N-(3-oxo-decanoyloxy)-L-leucyl-L-alanine

C19H34N2O5 (370.2468)


   

ST 24:4;O3

(20S,22E)-3beta-Hydroxychola-5,16,22-trien-24-oic Acid

C24H34O3 (370.2508)


3-Oxo-4,6-choladien-24-oic acid is an endogenous metabolite. 3-Oxo-4,6-choladien-24-oic acid exsists in the urine of patients with hepatobiliary disease[1].

   

6-((8Z,11Z,14Z)-heptadeca-8,11,14-trien-1-yl)salicylic acid

2-((8Z,11Z,14Z)-heptadeca-8,11,14-trien-1-yl)-6-hydroxybenzoic acid

C24H34O3 (370.2508)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D065093 - beta-Lactamase Inhibitors D004791 - Enzyme Inhibitors

   

dihydrogeranylidene bisindole

dihydrogeranylidene bisindole

C26H30N2 (370.2409)


   

3-PHENYL-1-(PYRIDIN-2-YL)-5,6,7,8,9,10,11,12,13,14-DECAHYDROCYCLODODECA[C]PYRIDINE

3-PHENYL-1-(PYRIDIN-2-YL)-5,6,7,8,9,10,11,12,13,14-DECAHYDROCYCLODODECA[C]PYRIDINE

C26H30N2 (370.2409)


   

2,2-(2,3-Dihydro-1H-indene-4,6-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)

2,2-(2,3-Dihydro-1H-indene-4,6-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)

C21H32B2O4 (370.2487)


   

Adb-chminaca, (+/-)-

Adb-chminaca, (+/-)-

C21H30N4O2 (370.2369)


   

MAFP

Methyl Arachidonyl Fluorophosphonate

C21H36FO2P (370.2437)


D004791 - Enzyme Inhibitors

   

CID 92536013

CID 92536013

C21H36FO2P (370.2437)


D004791 - Enzyme Inhibitors

   

(S)-N-(4-Carbamimidoylbenzyl)-1-(3-Cyclopentylpropanoyl)pyrrolidine-2-Carboxamide

(S)-N-(4-Carbamimidoylbenzyl)-1-(3-Cyclopentylpropanoyl)pyrrolidine-2-Carboxamide

C21H30N4O2 (370.2369)


   

methyl 8-[(2E)-2-[4-(5,5-dimethyl-1,3-dioxan-2-yl)butylidene]hydrazinyl]-8-oxooctanoate

methyl 8-[(2E)-2-[4-(5,5-dimethyl-1,3-dioxan-2-yl)butylidene]hydrazinyl]-8-oxooctanoate

C19H34N2O5 (370.2468)


   

3-Oxochola-4,6-dien-24-oic Acid

3-Oxochola-4,6-dien-24-oic Acid

C24H34O3 (370.2508)


A 3-oxo Delta(4)-steroid that is the 3-oxo derivative of chola-4,6-dien-24-oic acid. 3-Oxo-4,6-choladien-24-oic acid is an endogenous metabolite. 3-Oxo-4,6-choladien-24-oic acid exsists in the urine of patients with hepatobiliary disease[1].

   

3-Oxochola-1,4-dien-24-oic Acid

3-Oxochola-1,4-dien-24-oic Acid

C24H34O3 (370.2508)


   

(22E)-3beta-Hydroxychola-5,16,22-trien-24-oic Acid

(22E)-3beta-Hydroxychola-5,16,22-trien-24-oic Acid

C24H34O3 (370.2508)


   

3-Oxo-5beta-chola-7,11-dien-24-oic Acid

3-Oxo-5beta-chola-7,11-dien-24-oic Acid

C24H34O3 (370.2508)


   

3-Oxo-5beta-chola-7,9(11)-dien-24-oic Acid

3-Oxo-5beta-chola-7,9(11)-dien-24-oic Acid

C24H34O3 (370.2508)


   

3-Oxo-5beta-chola-8(14),11-dien-24-oic Acid

3-Oxo-5beta-chola-8(14),11-dien-24-oic Acid

C24H34O3 (370.2508)


   

(20S,22E)-3beta-Hydroxychola-5,16,22-trien-24-oic Acid

(20S,22E)-3beta-Hydroxychola-5,16,22-trien-24-oic Acid

C24H34O3 (370.2508)


   
   

Oxocholadienoic acid

Oxocholadienoic acid

C24H34O3 (370.2508)


   

8-hydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl 3-phenylprop-2-enoate

8-hydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl 3-phenylprop-2-enoate

C24H34O3 (370.2508)


   

(4e,6e)-7-[(1r,2s,4r,5r,6s,7s,9s,11r)-5-[(2e)-but-2-en-2-yl]-4,11-dimethyl-3,10-dioxatetracyclo[5.5.0.0²,⁴.0⁹,¹¹]dodecan-6-yl]-4-methylhepta-4,6-dien-3-one

(4e,6e)-7-[(1r,2s,4r,5r,6s,7s,9s,11r)-5-[(2e)-but-2-en-2-yl]-4,11-dimethyl-3,10-dioxatetracyclo[5.5.0.0²,⁴.0⁹,¹¹]dodecan-6-yl]-4-methylhepta-4,6-dien-3-one

C24H34O3 (370.2508)


   

(3r,5s)-5-(methoxymethyl)-3-(octadeca-13,17-dien-9,11-diyn-1-yl)oxolan-2-one

(3r,5s)-5-(methoxymethyl)-3-(octadeca-13,17-dien-9,11-diyn-1-yl)oxolan-2-one

C24H34O3 (370.2508)


   

(4e,8e)-1-(2-hydroxy-4-methoxyphenyl)-5,9,13-trimethyltetradeca-4,8,12-trien-1-one

(4e,8e)-1-(2-hydroxy-4-methoxyphenyl)-5,9,13-trimethyltetradeca-4,8,12-trien-1-one

C24H34O3 (370.2508)


   

2',3a,4,5',5',7,8'a-heptamethyl-2',3',4',4'a,7',8'-hexahydro-3h-spiro[1-benzofuran-2,1'-naphthalene]-6,6'-dione

2',3a,4,5',5',7,8'a-heptamethyl-2',3',4',4'a,7',8'-hexahydro-3h-spiro[1-benzofuran-2,1'-naphthalene]-6,6'-dione

C24H34O3 (370.2508)


   

(1r,3ar,4as,5r,7ar,9ar)-5-hydroxy-3a,5-dimethyl-1-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-7-oxo-1h,2h,3h,4h,4ah,6h,7ah,9ah-cyclopenta[f]azulene-8-carbaldehyde

(1r,3ar,4as,5r,7ar,9ar)-5-hydroxy-3a,5-dimethyl-1-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-7-oxo-1h,2h,3h,4h,4ah,6h,7ah,9ah-cyclopenta[f]azulene-8-carbaldehyde

C24H34O3 (370.2508)


   

2-[(8z,11z,14z)-heptadeca-8,11,14-trien-1-yl]-6-hydroxybenzoic acid

2-[(8z,11z,14z)-heptadeca-8,11,14-trien-1-yl]-6-hydroxybenzoic acid

C24H34O3 (370.2508)


   

(4r)-4-[(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

(4r)-4-[(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

C24H34O3 (370.2508)


   

7-[5-(but-2-en-2-yl)-4,11-dimethyl-3,10-dioxatetracyclo[5.5.0.0²,⁴.0⁹,¹¹]dodecan-6-yl]-4-methylhepta-4,6-dien-3-one

7-[5-(but-2-en-2-yl)-4,11-dimethyl-3,10-dioxatetracyclo[5.5.0.0²,⁴.0⁹,¹¹]dodecan-6-yl]-4-methylhepta-4,6-dien-3-one

C24H34O3 (370.2508)


   

methyl 19-(furan-2-yl)nonadeca-5,7-diynoate

methyl 19-(furan-2-yl)nonadeca-5,7-diynoate

C24H34O3 (370.2508)


   

(2s,2's,3ar,4'ar,8'as)-2',3a,4,5',5',7,8'a-heptamethyl-2',3',4',4'a,7',8'-hexahydro-3h-spiro[1-benzofuran-2,1'-naphthalene]-6,6'-dione

(2s,2's,3ar,4'ar,8'as)-2',3a,4,5',5',7,8'a-heptamethyl-2',3',4',4'a,7',8'-hexahydro-3h-spiro[1-benzofuran-2,1'-naphthalene]-6,6'-dione

C24H34O3 (370.2508)


   

(1r,2s,4ar,8s,8as)-8-hydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl (2e)-3-phenylprop-2-enoate

(1r,2s,4ar,8s,8as)-8-hydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl (2e)-3-phenylprop-2-enoate

C24H34O3 (370.2508)


   

4-{9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}pentanoic acid

4-{9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}pentanoic acid

C24H34O3 (370.2508)


   

2-(heptadeca-8,11,14-trien-1-yl)-6-hydroxybenzoic acid

2-(heptadeca-8,11,14-trien-1-yl)-6-hydroxybenzoic acid

C24H34O3 (370.2508)


   

(3r,5s)-5-(methoxymethyl)-3-[(13z)-octadeca-13,17-dien-9,11-diyn-1-yl]oxolan-2-one

(3r,5s)-5-(methoxymethyl)-3-[(13z)-octadeca-13,17-dien-9,11-diyn-1-yl]oxolan-2-one

C24H34O3 (370.2508)


   

(2e,4r)-4-[(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]pent-2-enoic acid

(2e,4r)-4-[(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]pent-2-enoic acid

C24H34O3 (370.2508)


   

4-{9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}pent-2-enoic acid

4-{9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}pent-2-enoic acid

C24H34O3 (370.2508)